Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001387131-18-005141

Director sold 182,800 shares at an average $6.59 ($1,204,561)

  • Director acquired 182,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bernick Brian · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-09-27 Exercise or conversion : show line 1 in the form +91,400 $0.10 $9,305 6,648,771 I
2018-09-27 Sale : show line 2 in the form −91,400 $6.63 $605,982 6,557,371 I
2018-09-28 Exercise or conversion : show line 3 in the form +91,400 $0.10 $9,305 6,648,771 I
2018-09-28 Sale : show line 4 in the form −91,400 $6.55 $598,579 6,557,371 I
Open-market sales · 182,800 sh · avg $6.59 · $1,204,561

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-09-27 Exercise or conversion : show line 5 in the form Non-Qualified Stock Option (right to buy) −91,400 1,188,710 I
2018-09-28 Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) −91,400 1,097,310 I
Loading xslF345X03/bernick-form4_092718.xml…